2		DISCONTINUED OPERATIONS
		Adcock Ingram Private Limited (India) and 53.47% of Ayrton Drug Manufacturing Limited (Ayrton) in Ghana were disposed of on 14 October 2016 and 7 December 2016 respectively. The loss of control on disposal resulted in the foreign currency translation reserve relating to both entities being recycled to profit and loss during the previous financial year.

			2017  R’000
2.1		STATEMENT OF COMPREHENSIVE INCOME
		REVENUE	120 174
		TURNOVER	118 901
		Cost of sales	(47 191)
		Gross profit	71 710
		Selling, distribution and marketing expenses	(39 077)
		Fixed and administrative expenses	(17 384)
		Trading profit	15 249
		Non-trading expenses	(6 833)
		Operating profit	8 416
		Finance income	1 273
		Finance costs	(2 014)
		Profit before taxation	7 675
		Taxation	(1 301)
		Profit for the period from discontinued operations	6 374
		Profit on disposal of the discontinued operations	34 758
		Profit for the period from discontinued operations	41 132
		Profit/(loss) attributable to:
		India	46 638
		Ayrton	(5 506)
			41 132
		Profit attributable to:
		Owners of the parent	39 903
		Non-controlling interests	1 229
			41 132
2.2		CASH INFLOW ON DISPOSAL
		Consideration received	338 601
		India	327 565
		Ayrton	11 036
		Net cash disposed of with the discontinued operations	(47 505)
		India	(48 807)
		Ayrton	1 302
		Net cash inflow	291 096

2.3		CASH FLOW STATEMENT
		Included in the Group's consolidated statement of cash flows for the previous financial year, were cash flows from the Indian and Ayrton discontinued operations. These cash flows were included in operating, investing and financing activities as follows:

			2017  R’000
		Cash inflow from operating activities	19 487
		Cash inflow from investing activities	744
		Cash outflow from financing activities	(78 388)
		Net cash outflow	(58 157)